Back

Chemogenetic inhibition of the noradrenergic locus coeruleus promotes the development of risk-taking decisional strategies and selectively enhances motor impulsivity in females

Chernoff, C. S.; Hynes, T. J.; Avramidis, D. K.; Ramaiah, S.; Lee, A. C.; Khoshnevis, A.; Hrelja, K. M.; Winstanley, C. A.

2026-07-04 neuroscience
10.64898/2026.07.02.736138 bioRxiv
Show abstract

The locus coeruleus noradrenaline (LC-NA) system is a key regulator of arousal, attention, and reward learning. Noradrenaline plays a critical role in impulse control, and recent evidence indicates the importance of noradrenaline signaling in cost-benefit decision making once choice strategies are established. However, whether the LC causally shapes the acquisition of decision strategies, and how this contribution may differ across sexes, remains unclear. We addressed these questions by chemogenetically inhibiting catecholaminergic neurons within the LC of adult tyrosine-hydroxylase Cre (TH::Cre) rats (n=69; 35 females) throughout acquisition of the cued rat gambling task (crGT), a probabilistic decision making paradigm that incorporates salient audiovisual reward-paired cues and simultaneously measures motor impulsivity. LC inhibition accelerated the development of risky choice strategies early in training in both males and females, reflected by impaired adoption of the most advantageous option and increased preference for risky options. Trial-by-trial analyses reveal that LC inhibition promoted switches in choice strategy following safe wins, while reducing switches away from risky options after both wins and losses. LC inhibition therefore seemed to encourage the repetition of actions that resulted in more uncertain outcomes. LC inhibition also selectively enhanced motor impulsivity in females, particularly early in training. These results provide causal evidence that the LC system guides the formation of optimal decisional strategies, while exerting sex-specific control over impulsive action.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
The Journal of Neuroscience
1025 papers in training set
Top 0.4%
18.6%
2
Neuropsychopharmacology
153 papers in training set
Top 0.2%
12.8%
3
eLife
5828 papers in training set
Top 10%
9.9%
4
Psychopharmacology
69 papers in training set
Top 0.2%
6.8%
5
eneuro
439 papers in training set
Top 2%
4.4%
50% of probability mass above
6
European Journal of Neuroscience
189 papers in training set
Top 0.7%
4.1%
7
Scientific Reports
3612 papers in training set
Top 29%
3.5%
8
Hormones and Behavior
45 papers in training set
Top 0.1%
3.5%
9
Nature Communications
5641 papers in training set
Top 34%
3.4%
10
Behavioural Brain Research
77 papers in training set
Top 0.4%
3.2%
11
Neuron
337 papers in training set
Top 4%
1.7%
12
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 30%
1.5%
13
Addiction Biology
51 papers in training set
Top 0.5%
1.5%
14
Cell Reports
1498 papers in training set
Top 20%
1.5%
15
Frontiers in Neuroscience
256 papers in training set
Top 4%
1.3%
16
Biological Psychiatry
137 papers in training set
Top 2%
1.1%
17
Addiction Neuroscience
17 papers in training set
Top 0.3%
1.1%
18
Behavioral Neuroscience
25 papers in training set
Top 0.2%
1.1%
19
PLOS ONE
5266 papers in training set
Top 59%
1.0%
20
Journal of Neurophysiology
302 papers in training set
Top 3%
1.0%
21
Nature Neuroscience
252 papers in training set
Top 5%
0.9%
22
Biological Psychiatry Global Open Science
60 papers in training set
Top 1%
0.9%
23
Communications Biology
993 papers in training set
Top 34%
0.6%
24
Science Advances
1243 papers in training set
Top 33%
0.6%
25
Molecular Psychiatry
282 papers in training set
Top 6%
0.6%
26
Neuropharmacology
68 papers in training set
Top 0.9%
0.6%